| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein serine kinase activity | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 6.91e-08 | 363 | 72 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 5.41e-07 | 446 | 72 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 7.22e-07 | 47 | 72 | 5 | GO:0004712 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | AURKA AURKC CERK PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 7.97e-06 | 709 | 72 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 9.43e-06 | 600 | 72 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | AURKA AURKC CERK PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 1.68e-05 | 764 | 72 | 12 | GO:0016301 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.26e-05 | 46 | 72 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | AURKA AURKC CERK PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL POLQ PLK3 AURKB | 2.69e-05 | 938 | 72 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 2.66e-04 | 7 | 72 | 2 | GO:0004711 | |
| GeneOntologyMolecularFunction | histone H3 kinase activity | 8.27e-04 | 12 | 72 | 2 | GO:0140996 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 1.71e-05 | 151 | 74 | 6 | GO:0007052 | |
| GeneOntologyCellularComponent | chromosome passenger complex | 8.11e-07 | 6 | 73 | 3 | GO:0032133 | |
| GeneOntologyCellularComponent | spindle pole centrosome | 3.80e-05 | 19 | 73 | 3 | GO:0031616 | |
| GeneOntologyCellularComponent | kinetochore | 4.08e-05 | 181 | 73 | 6 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 5.84e-05 | 193 | 73 | 6 | GO:0000779 | |
| GeneOntologyCellularComponent | spindle pole | 8.15e-05 | 205 | 73 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.79e-04 | 6 | 73 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | collagen trimer | 2.56e-04 | 88 | 73 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.32e-04 | 8 | 73 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.32e-04 | 8 | 73 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.32e-04 | 8 | 73 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | spindle midzone | 3.68e-04 | 40 | 73 | 3 | GO:0051233 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 4.07e-04 | 276 | 73 | 6 | GO:0000775 | |
| GeneOntologyCellularComponent | chromosomal region | 6.64e-04 | 421 | 73 | 7 | GO:0098687 | |
| GeneOntologyCellularComponent | condensed chromosome | 7.13e-04 | 307 | 73 | 6 | GO:0000793 | |
| GeneOntologyCellularComponent | PcG protein complex | 7.99e-04 | 52 | 73 | 3 | GO:0031519 | |
| GeneOntologyCellularComponent | spindle | 1.28e-03 | 471 | 73 | 7 | GO:0005819 | |
| GeneOntologyCellularComponent | centrosome | 1.40e-03 | 770 | 73 | 9 | GO:0005813 | |
| GeneOntologyCellularComponent | chromocenter | 1.77e-03 | 18 | 73 | 2 | GO:0010369 | |
| GeneOntologyCellularComponent | meiotic spindle | 1.98e-03 | 19 | 73 | 2 | GO:0072687 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.42e-03 | 21 | 73 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A2 AURKA COL4A4 AURKC COL6A1 EML5 MYOM3 CKAP5 CCT4 ALPG AURKB | 2.63e-03 | 1187 | 73 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | spindle microtubule | 3.40e-03 | 86 | 73 | 3 | GO:0005876 | |
| GeneOntologyCellularComponent | axon initial segment | 4.59e-03 | 29 | 73 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | microtubule organizing center | 4.60e-03 | 919 | 73 | 9 | GO:0005815 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.23e-03 | 320 | 73 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 6.10e-03 | 332 | 73 | 5 | GO:0005788 | |
| Domain | Aur | 5.73e-08 | 3 | 73 | 3 | IPR030616 | |
| Domain | Ser/Thr_kinase_AS | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 1.32e-07 | 357 | 73 | 11 | IPR008271 |
| Domain | S_TKc | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 1.39e-07 | 359 | 73 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 1.51e-07 | 362 | 73 | 11 | PS00108 |
| Domain | Pkinase | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 2.53e-07 | 381 | 73 | 11 | PF00069 |
| Domain | PROTEIN_KINASE_ATP | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 1.58e-06 | 459 | 73 | 11 | PS00107 |
| Domain | Prot_kinase_dom | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 2.91e-06 | 489 | 73 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 3.15e-06 | 493 | 73 | 11 | PS50011 |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 7.34e-06 | 69 | 73 | 5 | IPR020636 | |
| Domain | Kinase-like_dom | AURKA AURKC PLK2 VRK2 PIM2 DSTYK RPS6KB1 RPS6KB2 MASTL PLK3 AURKB | 7.76e-06 | 542 | 73 | 11 | IPR011009 |
| Domain | Ribosomal_S6_kinase | 1.51e-05 | 2 | 73 | 2 | IPR016238 | |
| Domain | Protein_kinase_ATP_BS | 1.64e-05 | 379 | 73 | 9 | IPR017441 | |
| Domain | POLO_box_2 | 4.51e-05 | 3 | 73 | 2 | IPR033695 | |
| Domain | - | 9.00e-05 | 4 | 73 | 2 | 3.30.1120.30 | |
| Domain | POLO_box | 9.00e-05 | 4 | 73 | 2 | PF00659 | |
| Domain | POLO_BOX | 9.00e-05 | 4 | 73 | 2 | PS50078 | |
| Domain | POLO_box_1 | 9.00e-05 | 4 | 73 | 2 | IPR033701 | |
| Domain | POLO_box_dom | 1.50e-04 | 5 | 73 | 2 | IPR000959 | |
| Domain | C4 | 2.24e-04 | 6 | 73 | 2 | SM00111 | |
| Domain | - | 2.24e-04 | 6 | 73 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.24e-04 | 6 | 73 | 2 | IPR001442 | |
| Domain | C4 | 2.24e-04 | 6 | 73 | 2 | PF01413 | |
| Domain | Peptidase_S8_Asp-AS | 2.24e-04 | 6 | 73 | 2 | IPR023827 | |
| Domain | NC1_IV | 2.24e-04 | 6 | 73 | 2 | PS51403 | |
| Domain | PrprotnconvertsP | 3.12e-04 | 7 | 73 | 2 | IPR002884 | |
| Domain | P_proprotein | 3.12e-04 | 7 | 73 | 2 | PF01483 | |
| Domain | S8_pro-domain | 3.12e-04 | 7 | 73 | 2 | IPR032815 | |
| Domain | - | 3.12e-04 | 7 | 73 | 2 | 3.30.70.850 | |
| Domain | S8_pro-domain | 3.12e-04 | 7 | 73 | 2 | PF16470 | |
| Domain | Collagen | 3.42e-04 | 85 | 73 | 4 | IPR008160 | |
| Domain | Collagen | 3.42e-04 | 85 | 73 | 4 | PF01391 | |
| Domain | Peptidase_S8_His-AS | 5.33e-04 | 9 | 73 | 2 | IPR022398 | |
| Domain | Peptidase_S8_Ser-AS | 5.33e-04 | 9 | 73 | 2 | IPR023828 | |
| Domain | Peptidase_S8_subtilisin-rel | 6.64e-04 | 10 | 73 | 2 | IPR015500 | |
| Domain | SUBTILASE_ASP | 6.64e-04 | 10 | 73 | 2 | PS00136 | |
| Domain | SUBTILASE_HIS | 6.64e-04 | 10 | 73 | 2 | PS00137 | |
| Domain | SUBTILASE_SER | 6.64e-04 | 10 | 73 | 2 | PS00138 | |
| Domain | - | 8.10e-04 | 11 | 73 | 2 | 3.40.50.200 | |
| Domain | Peptidase_S8/S53_dom | 8.10e-04 | 11 | 73 | 2 | IPR000209 | |
| Domain | Peptidase_S8 | 8.10e-04 | 11 | 73 | 2 | PF00082 | |
| Domain | Mit_uncoupling | 9.70e-04 | 12 | 73 | 2 | IPR002030 | |
| Domain | AGC-kinase_C | 1.37e-03 | 56 | 73 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.37e-03 | 56 | 73 | 3 | PS51285 | |
| Domain | S_TK_X | 1.37e-03 | 56 | 73 | 3 | SM00133 | |
| Domain | Propept_inh | 1.97e-03 | 17 | 73 | 2 | IPR009020 | |
| Domain | SEA | 3.31e-03 | 22 | 73 | 2 | PF01390 | |
| Domain | SEA | 3.61e-03 | 23 | 73 | 2 | PS50024 | |
| Domain | SEA_dom | 3.61e-03 | 23 | 73 | 2 | IPR000082 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.11e-06 | 20 | 57 | 4 | MM15061 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.60e-05 | 38 | 57 | 4 | MM14969 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.18e-05 | 41 | 57 | 4 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.40e-05 | 42 | 57 | 4 | M7169 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.89e-05 | 44 | 57 | 4 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.82e-05 | 50 | 57 | 4 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 6.07e-05 | 53 | 57 | 4 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.09e-05 | 57 | 57 | 4 | MM14713 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 8.09e-05 | 57 | 57 | 4 | M19888 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 8.66e-05 | 58 | 57 | 4 | M2049 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.06e-04 | 61 | 57 | 4 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.06e-04 | 61 | 57 | 4 | MM14637 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.20e-04 | 63 | 57 | 4 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.27e-04 | 64 | 57 | 4 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.52e-04 | 67 | 57 | 4 | M26999 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.61e-04 | 68 | 57 | 4 | M48322 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.48e-04 | 76 | 57 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.48e-04 | 76 | 57 | 4 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.48e-04 | 76 | 57 | 4 | MM14867 | |
| Pathway | PID_AURORA_A_PATHWAY | 2.60e-04 | 31 | 57 | 3 | M242 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 3.33e-04 | 7 | 57 | 2 | M47407 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 3.43e-04 | 34 | 57 | 3 | MM15325 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.64e-04 | 84 | 57 | 4 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.81e-04 | 85 | 57 | 4 | M16441 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.74e-04 | 90 | 57 | 4 | M631 | |
| Pathway | PID_AURORA_B_PATHWAY | 5.17e-04 | 39 | 57 | 3 | M14 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.08e-04 | 10 | 57 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 7.08e-04 | 10 | 57 | 2 | MM1560 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 7.08e-04 | 10 | 57 | 2 | M47400 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 8.41e-04 | 46 | 57 | 3 | M39805 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 8.63e-04 | 11 | 57 | 2 | M15422 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 8.63e-04 | 11 | 57 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 8.63e-04 | 11 | 57 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 8.63e-04 | 11 | 57 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 8.63e-04 | 11 | 57 | 2 | M47501 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.01e-03 | 49 | 57 | 3 | M27614 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.03e-03 | 12 | 57 | 2 | MM1526 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.03e-03 | 12 | 57 | 2 | M47393 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 1.03e-03 | 12 | 57 | 2 | M47887 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.15e-03 | 114 | 57 | 4 | MM14571 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.22e-03 | 13 | 57 | 2 | MM1347 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.22e-03 | 13 | 57 | 2 | M47398 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.22e-03 | 13 | 57 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.42e-03 | 14 | 57 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.42e-03 | 14 | 57 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.63e-03 | 15 | 57 | 2 | MM14922 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 1.63e-03 | 15 | 57 | 2 | M47663 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.63e-03 | 15 | 57 | 2 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.36e-03 | 18 | 57 | 2 | M27164 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.36e-03 | 18 | 57 | 2 | MM15336 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.36e-03 | 18 | 57 | 2 | MM14882 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.39e-03 | 339 | 57 | 6 | M39736 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.45e-03 | 140 | 57 | 4 | M587 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.91e-03 | 20 | 57 | 2 | M15394 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 3.21e-03 | 21 | 57 | 2 | M27634 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1 | 3.21e-03 | 21 | 57 | 2 | M932 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 3.32e-03 | 74 | 57 | 3 | M160 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.85e-03 | 23 | 57 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.85e-03 | 23 | 57 | 2 | MM1427 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.85e-03 | 23 | 57 | 2 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.85e-03 | 23 | 57 | 2 | M47900 | |
| Pathway | REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION | 4.19e-03 | 24 | 57 | 2 | M928 | |
| Pathway | WP_IL18_SIGNALING | 4.84e-03 | 273 | 57 | 5 | M39818 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 4.91e-03 | 26 | 57 | 2 | M47923 | |
| Pubmed | Aurora kinase B inhibits aurora kinase A to control maternal mRNA translation in mouse oocytes. | 9.25e-09 | 3 | 74 | 3 | 34636397 | |
| Pubmed | Deregulation of Aurora kinase gene expression in human testicular germ cell tumours. | 9.25e-09 | 3 | 74 | 3 | 20629650 | |
| Pubmed | Differential Selective Pressures Experienced by the Aurora Kinase Gene Family. | 9.25e-09 | 3 | 74 | 3 | 29283376 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 19649632 | ||
| Pubmed | SAR156497, an exquisitely selective inhibitor of aurora kinases. | 9.25e-09 | 3 | 74 | 3 | 25369539 | |
| Pubmed | Gene expression of Aurora kinases in prostate cancer and nodular hyperplasia tissues. | 9.25e-09 | 3 | 74 | 3 | 23075505 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 32452402 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 28359584 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 30415701 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 24632603 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 19774610 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 18353803 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 31521144 | ||
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 12434334 | ||
| Pubmed | 5.14e-07 | 8 | 74 | 3 | 14602875 | ||
| Pubmed | Centrosome-related genes, genetic variation, and risk of breast cancer. | 2.70e-06 | 102 | 74 | 5 | 20508983 | |
| Pubmed | AURKA PLK2 HECW2 RPS6KB1 RPS6KB2 ATP2C2 TNFAIP1 PLK3 BAP1 AURKB | 3.34e-06 | 730 | 74 | 10 | 34857952 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25882311 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16572587 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23114921 | ||
| Pubmed | Polymorphisms in MicroRNA Binding Sites Predict Colorectal Cancer Survival. | 4.47e-06 | 2 | 74 | 2 | 28138309 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33003310 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 35255953 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16912073 | ||
| Pubmed | Aurora kinases as targets in drug-resistant neuroblastoma cells. | 4.47e-06 | 2 | 74 | 2 | 25268132 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23092930 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18758466 | ||
| Pubmed | Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis. | 4.47e-06 | 2 | 74 | 2 | 27493124 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33725274 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24683001 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15499654 | ||
| Pubmed | Aurora kinase genetic polymorphisms: an association study in Down syndrome and spontaneous abortion. | 4.47e-06 | 2 | 74 | 2 | 35218477 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25807528 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22222631 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24603334 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33277547 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28369513 | ||
| Pubmed | Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. | 4.47e-06 | 2 | 74 | 2 | 11784863 | |
| Pubmed | Mitotic kinases as regulators of cell division and its checkpoints. | 4.47e-06 | 2 | 74 | 2 | 11413462 | |
| Pubmed | Association of the AURKA and AURKC gene polymorphisms with an increased risk of gastric cancer. | 4.47e-06 | 2 | 74 | 2 | 27270838 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20932932 | ||
| Pubmed | Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. | 4.47e-06 | 2 | 74 | 2 | 10523496 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20865660 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28843004 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 17550782 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18174371 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20732714 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22463590 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24128992 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 27438654 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30443360 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 24586209 | ||
| Pubmed | Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells. | 4.47e-06 | 2 | 74 | 2 | 25667100 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33172929 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22828320 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 33172986 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20368716 | ||
| Pubmed | Gene amplification of ribosomal protein S6 kinase-1 and -2 in gastric cancer. | 4.47e-06 | 2 | 74 | 2 | 23393338 | |
| Pubmed | Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer. | 4.47e-06 | 2 | 74 | 2 | 18628459 | |
| Pubmed | Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. | 4.47e-06 | 2 | 74 | 2 | 33123754 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31597600 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20080710 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23788275 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19059698 | ||
| Pubmed | Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. | 4.47e-06 | 2 | 74 | 2 | 22940834 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26141684 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26443806 | ||
| Pubmed | Allosteric modulation of a human protein kinase with monobodies. | 4.47e-06 | 2 | 74 | 2 | 31239342 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9822608 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12529391 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9804755 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26808391 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26660542 | ||
| Pubmed | Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer. | 4.47e-06 | 2 | 74 | 2 | 20953835 | |
| Pubmed | Aurora kinases as prognostic biomarkers in ovarian carcinoma. | 4.47e-06 | 2 | 74 | 2 | 19157502 | |
| Pubmed | Antiproliferative effect of Aurora kinase targeting in mesothelioma. | 4.47e-06 | 2 | 74 | 2 | 20371132 | |
| Pubmed | Spatial Compartmentalization Specializes the Function of Aurora A and Aurora B. | 4.47e-06 | 2 | 74 | 2 | 25987563 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15060135 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22778418 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18846252 | ||
| Pubmed | Expression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis. | 4.47e-06 | 2 | 74 | 2 | 22809428 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26616283 | ||
| Pubmed | Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme. | 4.47e-06 | 2 | 74 | 2 | 34465813 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22412899 | ||
| Pubmed | Differential functions of the Aurora-B and Aurora-C kinases in mammalian spermatogenesis. | 4.47e-06 | 2 | 74 | 2 | 17192404 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | COL4A2 USP5 AARS1 ABCF1 TXNDC5 RPS6KB1 ETFA SLC25A10 MASTL CCT4 | 8.05e-06 | 807 | 74 | 10 | 30575818 |
| Pubmed | Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. | 1.34e-05 | 3 | 74 | 2 | 17726514 | |
| Pubmed | mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. | 1.34e-05 | 3 | 74 | 2 | 19535330 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24756216 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21123620 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15589845 | ||
| Pubmed | Adhesion induced expression of the serine/threonine kinase Fnk in human macrophages. | 1.34e-05 | 3 | 74 | 2 | 11039900 | |
| Pubmed | Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis. | 1.34e-05 | 3 | 74 | 2 | 16386730 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19494039 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 23829974 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 3089234 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 30077875 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18006852 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 10523297 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 33854138 | ||
| Interaction | AURKC interactions | 1.85e-05 | 43 | 74 | 4 | int:AURKC | |
| Interaction | SGK2 interactions | 1.85e-05 | 43 | 74 | 4 | int:SGK2 | |
| Interaction | TCEAL4 interactions | 2.43e-05 | 46 | 74 | 4 | int:TCEAL4 | |
| GeneFamily | Collagens | 5.53e-06 | 46 | 46 | 4 | 490 | |
| GeneFamily | Proprotein convertase subtilisin/kexin family | 2.25e-04 | 9 | 46 | 2 | 973 | |
| GeneFamily | Solute carriers | 3.19e-03 | 395 | 46 | 5 | 752 | |
| GeneFamily | Ubiquitin specific peptidases | 8.94e-03 | 56 | 46 | 2 | 366 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.09e-02 | 181 | 46 | 3 | 694 | |
| Coexpression | VANTVEER_BREAST_CANCER_BRCA1_UP | 2.55e-06 | 34 | 74 | 4 | M16737 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.95e-06 | 40 | 74 | 4 | M5887 | |
| Coexpression | NABA_COLLAGENS | 6.64e-06 | 43 | 74 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 7.29e-06 | 44 | 74 | 4 | M3005 | |
| Coexpression | FINETTI_BREAST_CANCER_KINOME_RED | 1.18e-05 | 16 | 74 | 3 | M9389 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 2.14e-05 | 199 | 74 | 6 | M8979 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 5.43e-05 | 610 | 74 | 9 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 5.78e-05 | 615 | 74 | 9 | M8673 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 7.39e-05 | 153 | 74 | 5 | M5588 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 7.86e-05 | 155 | 74 | 5 | MM1259 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 8.82e-05 | 650 | 74 | 9 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 9.79e-05 | 659 | 74 | 9 | MM1040 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.02e-08 | 179 | 74 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.72e-08 | 187 | 74 | 7 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.63e-08 | 195 | 74 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.99e-07 | 170 | 74 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.65e-07 | 190 | 74 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.89e-07 | 191 | 74 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 8.38e-07 | 193 | 74 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 8.64e-07 | 194 | 74 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.64e-07 | 194 | 74 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 8.64e-07 | 194 | 74 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.90e-07 | 195 | 74 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.17e-07 | 196 | 74 | 6 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-07 | 197 | 74 | 6 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.44e-07 | 197 | 74 | 6 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.52e-06 | 146 | 74 | 5 | 669001b772b6d6109a09727619ed5829122b48db | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.69e-06 | 167 | 74 | 5 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.95e-06 | 168 | 74 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.06e-05 | 174 | 74 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 175 | 74 | 5 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 176 | 74 | 5 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 176 | 74 | 5 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 178 | 74 | 5 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-05 | 179 | 74 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-05 | 180 | 74 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.25e-05 | 180 | 74 | 5 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-05 | 183 | 74 | 5 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 184 | 74 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.39e-05 | 184 | 74 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 184 | 74 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 184 | 74 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-05 | 185 | 74 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 185 | 74 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 185 | 74 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.46e-05 | 186 | 74 | 5 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.50e-05 | 187 | 74 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 188 | 74 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-05 | 188 | 74 | 5 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 188 | 74 | 5 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 188 | 74 | 5 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 188 | 74 | 5 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 188 | 74 | 5 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-05 | 189 | 74 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 189 | 74 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.58e-05 | 189 | 74 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.62e-05 | 190 | 74 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-05 | 190 | 74 | 5 | 632d5dc11765053366d61f0a0c7916111cea4f50 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 190 | 74 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.62e-05 | 190 | 74 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.66e-05 | 191 | 74 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-05 | 192 | 74 | 5 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.70e-05 | 192 | 74 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 1.70e-05 | 192 | 74 | 5 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 192 | 74 | 5 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 193 | 74 | 5 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 193 | 74 | 5 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.75e-05 | 193 | 74 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 1.75e-05 | 193 | 74 | 5 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-05 | 193 | 74 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 193 | 74 | 5 | 0373984547cefc0cbd77f8e795d508f6fcebc6c8 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.79e-05 | 194 | 74 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 1.79e-05 | 194 | 74 | 5 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 194 | 74 | 5 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-05 | 194 | 74 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 195 | 74 | 5 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.84e-05 | 195 | 74 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.84e-05 | 195 | 74 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 195 | 74 | 5 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 196 | 74 | 5 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.88e-05 | 196 | 74 | 5 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 196 | 74 | 5 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-05 | 196 | 74 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 197 | 74 | 5 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 197 | 74 | 5 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-05 | 197 | 74 | 5 | 15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.98e-05 | 198 | 74 | 5 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.98e-05 | 198 | 74 | 5 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.98e-05 | 198 | 74 | 5 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-05 | 198 | 74 | 5 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-05 | 199 | 74 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, condition lineage and cell class | 2.02e-05 | 199 | 74 | 5 | 1b17e6d5e6b994dec65efae2667f4f1f438161b1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 74 | 5 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 74 | 5 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 3.04e-06 | 192 | 74 | 7 | 1599_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.04e-06 | 192 | 74 | 7 | 4330_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 3.14e-06 | 193 | 74 | 7 | 6646_DN | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A | 3.36e-06 | 195 | 74 | 7 | 2970_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 3.60e-06 | 197 | 74 | 7 | 6181_DN | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | 3.72e-06 | 198 | 74 | 7 | 6816_DN | |
| Drug | Mecamylamine hydrochloride [826-39-1]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 3.72e-06 | 198 | 74 | 7 | 7023_UP | |
| Drug | VX680 | 5.34e-06 | 11 | 74 | 3 | ctd:C484810 | |
| Drug | 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate | 1.04e-05 | 2 | 74 | 2 | ctd:C520647 | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 3.94e-05 | 193 | 74 | 6 | 3100_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 4.06e-05 | 194 | 74 | 6 | 6893_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.06e-05 | 194 | 74 | 6 | 2959_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | 4.06e-05 | 194 | 74 | 6 | 4301_DN | |
| Drug | RH 1 | 4.09e-05 | 59 | 74 | 4 | CID000394347 | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.17e-05 | 195 | 74 | 6 | 6310_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.29e-05 | 196 | 74 | 6 | 4296_DN | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 2695_DN | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; HL60; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 2738_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 2080_DN | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 1170_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 6827_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 2980_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 4805_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 4194_DN | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 4.67e-05 | 199 | 74 | 6 | 2693_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 4.81e-05 | 200 | 74 | 6 | 6359_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; HL60; HT_HG-U133A | 4.81e-05 | 200 | 74 | 6 | 3010_DN | |
| Drug | MLN 8237 | 6.23e-05 | 4 | 74 | 2 | ctd:C550258 | |
| Drug | SQ20006 | 1.04e-04 | 5 | 74 | 2 | CID000162356 | |
| Drug | x MC | 1.39e-04 | 31 | 74 | 3 | CID000017563 | |
| Drug | VX-680 | 1.39e-04 | 31 | 74 | 3 | CID005494449 | |
| Drug | UKI-1D | 1.55e-04 | 6 | 74 | 2 | CID003392032 | |
| Drug | SP600125 | 1.75e-04 | 362 | 74 | 7 | CID000008515 | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.70e-04 | 188 | 74 | 5 | 2079_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 3.70e-04 | 188 | 74 | 5 | 5596_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 3.70e-04 | 188 | 74 | 5 | 6186_DN | |
| Drug | cupric oxide | 3.76e-04 | 543 | 74 | 8 | ctd:C030973 | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.79e-04 | 189 | 74 | 5 | 1285_UP | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; HL60; HT_HG-U133A | 3.88e-04 | 190 | 74 | 5 | 2539_UP | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 3.97e-04 | 191 | 74 | 5 | 7070_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.97e-04 | 191 | 74 | 5 | 6839_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A | 4.07e-04 | 192 | 74 | 5 | 1929_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 4.07e-04 | 192 | 74 | 5 | 3804_DN | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 4.17e-04 | 193 | 74 | 5 | 2930_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 4.17e-04 | 193 | 74 | 5 | 6846_UP | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 4.27e-04 | 194 | 74 | 5 | 4848_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 4.27e-04 | 194 | 74 | 5 | 1217_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 4.27e-04 | 194 | 74 | 5 | 3807_DN | |
| Drug | geldanamycin; Down 200; 1uM; HL60; HT_HG-U133A | 4.27e-04 | 194 | 74 | 5 | 1169_DN | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; HL60; HT_HG-U133A | 4.27e-04 | 194 | 74 | 5 | 6160_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 4.27e-04 | 194 | 74 | 5 | 2504_DN | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 4412_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 3802_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 3669_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 7377_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 5200_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 4235_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 3871_DN | |
| Drug | Procyclidine hydrochloride [1508-76-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 4817_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; PC3; HG-U133A | 4.37e-04 | 195 | 74 | 5 | 434_DN | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 4682_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; HL60; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 2333_UP | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; HL60; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 1345_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 6770_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 195 | 74 | 5 | 7327_DN | |
| Drug | quercetin dihydrate; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.47e-04 | 196 | 74 | 5 | 917_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 5230_UP | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 2935_DN | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 1864_DN | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 3263_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 2318_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 3740_DN | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 1294_DN | |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 5861_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 7298_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 1819_DN | |
| Drug | PNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 6563_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 2818_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 2314_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 3256_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 2531_DN | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; HL60; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 2953_DN | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 4257_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 7300_UP | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.47e-04 | 196 | 74 | 5 | 5759_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 6412_DN | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; HL60; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 3026_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; PC3; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 3728_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 5810_DN | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 6800_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; PC3; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 7304_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 2545_DN | |
| Drug | rottlerin; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.58e-04 | 197 | 74 | 5 | 825_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 5479_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 2554_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 6466_DN | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; HL60; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 2401_UP | |
| Drug | aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 1145_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 4501_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; HL60; HT_HG-U133A | 4.58e-04 | 197 | 74 | 5 | 2524_UP | |
| Disease | body mass index, fasting blood glucose measurement | 7.89e-06 | 51 | 73 | 4 | EFO_0004340, EFO_0004465 | |
| Disease | multiple acyl-CoA dehydrogenase deficiency (implicated_via_orthology) | 1.81e-05 | 3 | 73 | 2 | DOID:0060358 (implicated_via_orthology) | |
| Disease | brain cancer (implicated_via_orthology) | 3.63e-05 | 26 | 73 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 4.55e-05 | 28 | 73 | 3 | DOID:8634 (is_marker_for) | |
| Disease | Aneuploidy | 6.01e-05 | 5 | 73 | 2 | C0002938 | |
| Disease | migraine disorder, HOMA-B | 6.01e-05 | 5 | 73 | 2 | EFO_0004469, MONDO_0005277 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.36e-04 | 105 | 73 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Chromosomal Instability | 1.67e-04 | 8 | 73 | 2 | C1257806 | |
| Disease | alcohol dependence (implicated_via_orthology) | 2.15e-04 | 9 | 73 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Alzheimer disease, fasting blood glucose measurement | 2.15e-04 | 9 | 73 | 2 | EFO_0004465, MONDO_0004975 | |
| Disease | brain measurement, neuroimaging measurement | 4.24e-04 | 550 | 73 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | ovary epithelial cancer (is_marker_for) | 4.63e-04 | 13 | 73 | 2 | DOID:2152 (is_marker_for) | |
| Disease | urinary albumin to creatinine ratio | 1.03e-03 | 179 | 73 | 4 | EFO_0007778 | |
| Disease | corneal hysteresis | 1.11e-03 | 20 | 73 | 2 | EFO_0010066 | |
| Disease | Renal glomerular disease | 1.48e-03 | 23 | 73 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.48e-03 | 23 | 73 | 2 | C4521256 | |
| Disease | cortical thickness | 1.67e-03 | 1113 | 73 | 9 | EFO_0004840 | |
| Disease | aspartate aminotransferase measurement | 1.74e-03 | 904 | 73 | 8 | EFO_0004736 | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 1.75e-03 | 25 | 73 | 2 | EFO_0004465, EFO_0004466, EFO_0004469 | |
| Disease | grip strength measurement | 1.77e-03 | 350 | 73 | 5 | EFO_0006941 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.19e-03 | 28 | 73 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 2.19e-03 | 28 | 73 | 2 | DOID:12236 (biomarker_via_orthology) | |
| Disease | handedness | 2.33e-03 | 106 | 73 | 3 | EFO_0009902 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYGLVGPNGKGKTTL | 331 | Q8NE71 | |
| GRPLGKGKFGNVYLA | 46 | Q9UQB9 | |
| AGGRYLGKKVQFRKP | 151 | P55199 | |
| GRPLGKGKFGNVYLA | 136 | O14965 | |
| KGGGLGNKYVQLNVG | 21 | Q13829 | |
| RFLPGGKMGYLKRNG | 316 | Q9H8M2 | |
| ISRGAFGKVYLGQKG | 41 | Q96GX5 | |
| VYGSGKKYIGPCGGR | 36 | P53420 | |
| KGFGPGYLGGFLLVL | 1456 | P53420 | |
| LKGYLGAKGIQGMPG | 1001 | P08572 | |
| GDKGAPGIFGLKGYR | 1281 | P08572 | |
| LRYKGKGTGKPGALS | 416 | Q92560 | |
| KLGPLAFYKGLVPAG | 246 | Q9UBX3 | |
| GSRGLGQGTPKGKIY | 1136 | A2RUS2 | |
| KKLGFSGGGRQYQAL | 11 | O75185 | |
| SVPGQQGKYRGAKGS | 736 | Q8WWM7 | |
| EFRGPSGLLVYQGKG | 141 | P00387 | |
| RKEGVGGFYKGIAPN | 271 | Q9H2D1 | |
| YRKLETKGYGQGPGK | 1201 | Q9P2P5 | |
| PRYGFGEAGKPKFGI | 221 | Q13451 | |
| KYKAGRLPLGKIGRG | 716 | Q674X7 | |
| GKGRTYGSKYPGLIK | 236 | Q5JYT7 | |
| AFKALGGKGPYTLQG | 101 | P55899 | |
| FEYGIKKGRQGLGSI | 326 | P29122 | |
| RNGGVYPGPSGEKKL | 6 | O43526 | |
| GAGAGKPPKRNAFYR | 61 | O43526 | |
| APGLKLRGTGLYKAA | 216 | Q6UWM7 | |
| PVFGDYGEKRRGGKK | 91 | O15018 | |
| FELLRVLGKGGYGKV | 91 | P23443 | |
| VLGKGGYGKVFQVRK | 96 | P23443 | |
| KPKLGQELGRGQYGV | 651 | Q6XUX3 | |
| LYGNGPGYVLKDGAR | 411 | P10696 | |
| LGYGFNRPYAAGGKK | 286 | Q9H7U1 | |
| GLAVGLRKKFGQYAG | 346 | Q14008 | |
| QKRGPGFKYASNLPG | 731 | Q8NHM5 | |
| GEPSAGLGEYLKGRK | 216 | Q9HC52 | |
| DIAPRGVKGAKGYRG | 561 | P12109 | |
| FINPFGGKGQGKRIY | 136 | Q8TCT0 | |
| QAVGKGLLPMGRGKY | 2271 | O75417 | |
| GGKNPFLGIAYLVVG | 311 | Q3MIR4 | |
| YPKFNFVGKLLGPRG | 71 | Q5VWX1 | |
| GNGKRLFYRMPGGKE | 471 | Q05BV3 | |
| GPGYIDIPKGKGKQF | 841 | Q49AJ0 | |
| GGGFLGRKKVPYLAS | 761 | Q9Y597 | |
| CYGTKGPKGNRGLNG | 1441 | A6NMZ7 | |
| KNPYAQGRGKFFGLF | 261 | Q9GZK4 | |
| LVGGYIGGLVPKLKY | 301 | Q9NP80 | |
| LKSGFGTYPGRKRGA | 106 | Q7Z4K8 | |
| CFELLRVLGKGGYGK | 66 | Q9UBS0 | |
| RVLGKGGYGKVFQVR | 71 | Q9UBS0 | |
| PFLGGLGGGYQKTLV | 86 | A1A5C7 | |
| EYRLGPLLGKGGFGT | 31 | Q9P1W9 | |
| GGRGLKSGENFKLLY | 221 | P13804 | |
| AGGRGKGAYQDRDKP | 16 | P50991 | |
| PGPALGYFRGDEKGK | 171 | O94993 | |
| RKGYGILPGFKGVTV | 206 | Q8IZF2 | |
| GKLYGRGATDNKGPV | 156 | Q96KN2 | |
| DFEIGRPLGKGKFGN | 76 | Q96GD4 | |
| RPLGKGKFGNVYLAR | 81 | Q96GD4 | |
| FLRKPGGNLGKVYQP | 6 | Q70EK8 | |
| KELPGKFLLGYQPRG | 1466 | Q7KZ85 | |
| YDPGYKVKQRLGGGR | 61 | Q96B54 | |
| TYLKGRLLGKGGFAR | 61 | Q9H4B4 | |
| QKGTGARPYTGKVGA | 271 | P49588 | |
| KGRKVPRHFLVSGGY | 306 | Q5TEJ8 | |
| PYLAGGDARGKKLPN | 941 | O94964 | |
| YFGAKLHRPKIIGAG | 101 | Q9NYB5 | |
| GGPKDFGAGLKYNSR | 11 | Q9Y5Y6 | |
| AAKRQDGGLFKGPPY | 86 | Q9NQB0 | |
| GKAALVGIYGRKGLP | 471 | Q6N022 | |
| LIGFFGKGYGKNKEP | 491 | P55017 | |
| GKGYGKNKEPVRGYL | 496 | P55017 | |
| YIGKGGLARHFKLNP | 206 | A8K0R7 | |
| QGVRGYPTLKLFKPG | 131 | Q8NBS9 | |
| RYCRGKVLGKGGFAK | 81 | Q9NYY3 | |
| GGCGRVGYLKKAFNL | 181 | O75127 | |
| LLQKMGYVPGRGLGK | 156 | Q9UBB9 | |
| GPKVRDGPGKYQLFA | 791 | P45974 | |
| LGKKIGSGGFGLIYL | 31 | Q86Y07 | |
| PGGGKRKGKAQYVLA | 11 | Q9NXG2 | |
| KPPKRRGGGKILGYF | 721 | Q5VTT5 | |
| KAFEYGVKQGRQGKG | 286 | P29120 |